294 related articles for article (PubMed ID: 27107814)
1. Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.
Silkoff PE; Laviolette M; Singh D; FitzGerald JM; Kelsen S; Backer V; Porsbjerg C; Girodet PO; Berger P; Kline JN; Khatri S; Chanez P; Susulic VS; Barnathan ES; Baribaud F; Loza MJ;
Respir Res; 2016 Apr; 17():43. PubMed ID: 27107814
[TBL] [Abstract][Full Text] [Related]
2. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
[TBL] [Abstract][Full Text] [Related]
3. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
[TBL] [Abstract][Full Text] [Related]
4. Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function.
Brooks CR; Van Dalen CJ; Harding E; Hermans IF; Douwes J
BMC Pulm Med; 2017 Dec; 17(1):169. PubMed ID: 29202821
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
6. Fractioned exhaled nitric oxide (FE(NO)) is not a sufficiently reliable test for monitoring asthma in pregnancy.
Nittner-Marszalska M; Liebhart J; Pawłowicz R; Kazimierczak A; Marszalska H; Kraus-Filarska M; Panaszek B; Dor-Wojnarowska A
Nitric Oxide; 2013 Sep; 33():56-63. PubMed ID: 23756211
[TBL] [Abstract][Full Text] [Related]
7. Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma.
Kupczyk M; Dahlén B; Sterk PJ; Nizankowska-Mogilnicka E; Papi A; Bel EH; Chanez P; Howarth PH; Holgate ST; Brusselle G; Siafakas NM; Gjomarkaj M; Dahlén SE;
Allergy; 2014 Sep; 69(9):1198-204. PubMed ID: 25039610
[TBL] [Abstract][Full Text] [Related]
8. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
9. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
Yin SS; Liu H; Gao X
Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
[TBL] [Abstract][Full Text] [Related]
10. Phenotype classification using the combination of lung sound analysis and fractional exhaled nitric oxide for evaluating asthma treatment.
Shimoda T; Obase Y; Nagasaka Y; Asai S
Allergol Int; 2018 Apr; 67(2):253-258. PubMed ID: 29066290
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.
Anderson WJ; Short PM; Williamson PA; Lipworth BJ
Chest; 2012 Dec; 142(6):1553-1561. PubMed ID: 23364390
[TBL] [Abstract][Full Text] [Related]
12. Spirometry-Adjusted Fraction of Exhaled Nitric Oxide Allows Asthma Diagnosis in Children, Adolescents, and Young Adults.
Grzelewski T; Stelmach W; Stelmach R; Janas A; Grzelewska A; Witkowski K; Makandjou-Ola E; Majak P; Stelmach I
Respir Care; 2016 Feb; 61(2):162-72. PubMed ID: 26628565
[TBL] [Abstract][Full Text] [Related]
13. Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma.
Wang W; Huang KW; Wu BM; Wang YJ; Wang C
Chin Med J (Engl); 2012 Sep; 125(17):3157-60. PubMed ID: 22932198
[TBL] [Abstract][Full Text] [Related]
14. Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity.
Chien JW; Lin CY; Yang KD; Lin CH; Kao JK; Tsai YG
Clin Exp Allergy; 2013 Sep; 43(9):1018-26. PubMed ID: 23957337
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic predictors of response to oral glucocorticosteroids in severe asthma.
Kupczyk M; Haque S; Middelveld RJ; Dahlén B; Dahlén SE;
Respir Med; 2013 Oct; 107(10):1521-30. PubMed ID: 23993706
[TBL] [Abstract][Full Text] [Related]
16. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.
Crespo A; Giner J; Torrejón M; Belda A; Mateus E; Granel C; Torrego A; Ramos-Barbón D; Plaza V
J Asthma; 2016 Jun; 53(5):459-64. PubMed ID: 26785727
[TBL] [Abstract][Full Text] [Related]
17. The interpretation of exhaled nitric oxide values in children with asthma depends on the degree of bronchoconstriction and the levels of asthma severity.
Grzelewski T; Majak P; Jerzyńska J; Stelmach W; Stelmach R; Janas A; Grzelewska A; Witkowski K; Makandjou-Ola E; Stelmach I
Respir Care; 2014 Sep; 59(9):1404-11. PubMed ID: 24381190
[TBL] [Abstract][Full Text] [Related]
18. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.
Silkoff PE; Laviolette M; Singh D; FitzGerald JM; Kelsen S; Backer V; Porsbjerg CM; Girodet PO; Berger P; Kline JN; Chupp G; Susulic VS; Barnathan ES; Baribaud F; Loza MJ;
J Allergy Clin Immunol; 2017 Sep; 140(3):710-719. PubMed ID: 28089872
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of exhaled nitric oxide response to β2-agonists in asthmatic patients according to the site of bronchodilation.
Michils A; Malinovschi A; Haccuria A; Michiels S; Van Muylem A
J Allergy Clin Immunol; 2016 Mar; 137(3):806-12. PubMed ID: 26688519
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of bronchial provocation and FENO measurement for asthma diagnosis--results of a delayed type of diagnostic study.
Schneider A; Faderl B; Schwarzbach J; Welker L; Karsch-Völk M; Jörres RA
Respir Med; 2014 Jan; 108(1):34-40. PubMed ID: 24315470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
